Migraine is a leading cause of disability worldwide. A minority of individuals with migraine
develop resistant or refractory conditions characterised by≥ 8 monthly days of debilitating …

Abstract The new Calcitonin Gene-Related Peptide (CGRP)-targeted therapies have proven
high efficacy and tolerability in episodic and chronic migraine. Eptinezumab is a humanized …

This survey investigated the prevalence of de novo widespread musculoskeletal post-
COVID pain and risk factors for its development in nonhospitalized COVID-19 survivors. A …

Background Refractory migraine is a poorly described complication of migraine in which
migraine has chronified and become resistant to standard treatments. The true prevalence is …

Background Recent animal and clinical findings consistently highlight the critical role of
calcitonin gene-related peptide (CGRP) in chronic migraine (CM) and related emotional …

Background Chronic headache disorders are disabling. The CHESS trial studied the effects
of a short non-pharmacological intervention of education with self-management support for …

Background: Migraine is characterized by sudden acute episodes of pain, with a global
prevalence of 18% among all age groups. It is the second leading cause of years lived with …

Headache and visceral pain are common clinical painful conditions, which often co-exist in
the same patients. Numbers relative to their co-occurrence suggest possible common …

Die Migräne als häufige neurologische Erkrankung (10-15% der Bevölkerung) ist mit
zahlreichen Komorbiditäten assoziiert, insbesondere mit anderen Schmerzsyndromen …

Fibromyalgia (FM) is a common, complex, and chronic pain disorder characterized by
widespread musculoskeletal pain, fatigue, and tenderness in localized areas. A multitude of …